3 hydroxyisobutyric aciduria

A rare metabolic disorder

Template:Medical condition (new)

3-Hydroxyisobutyric aciduria is a rare metabolic disorder characterized by the accumulation of 3-hydroxyisobutyric acid in the body. This condition is caused by a deficiency in the enzyme responsible for the metabolism of valine, an essential amino acid.

Pathophysiology

3-Hydroxyisobutyric aciduria results from a defect in the valine catabolic pathway. Normally, valine is broken down into several intermediates, one of which is 3-hydroxyisobutyric acid. In individuals with this disorder, the enzyme responsible for further metabolizing 3-hydroxyisobutyric acid is deficient or absent, leading to its accumulation in the body.

Clinical Presentation

Patients with 3-hydroxyisobutyric aciduria may present with a variety of symptoms, which can include:

• Developmental delay
• Hypotonia
• Seizures
• Metabolic acidosis

The severity and range of symptoms can vary widely among affected individuals.

Diagnosis

The diagnosis of 3-hydroxyisobutyric aciduria is typically made through urine organic acid analysis, which reveals elevated levels of 3-hydroxyisobutyric acid. Genetic testing can confirm the diagnosis by identifying mutations in the gene responsible for the enzyme deficiency.

Treatment

There is currently no cure for 3-hydroxyisobutyric aciduria. Treatment is primarily supportive and may include:

• Dietary management to limit valine intake
• Physical therapy to address developmental delays and hypotonia
• Anticonvulsant medications to control seizures

Prognosis

The prognosis for individuals with 3-hydroxyisobutyric aciduria varies depending on the severity of the enzyme deficiency and the effectiveness of supportive treatments. Early intervention and management can improve outcomes for some patients.

Related pages

• Metabolic disorder
• Valine
• Organic acidemia

Gallery

• 
  3-Hydroxyisobutyric acid